comprehensive -WSS

comprehensive

author：fashion 2025-09-01 15:19:06 - browse：55549

Janet Woodcock -- health policy coverage from STAT — Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images

WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s drawn the battle plans for the agency’s next chapter.

Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of therapies and several clashes with Congress and patient advocates. In recent years, she also warded off attacks on the agency’s decisionmaking during the Covid-19 pandemic, particularly when the agency veteran took the acting commissioner role during President Biden’s long search for a permanent leader, and took charge of a vast reorganization plan sparked by the baby formula crisis.

Some of those efforts still hang in the balance as she departs this week. Critics argue that under her oversight, the drug division worked too closely with pharmaceutical companies to give broad approvals to new medicines like Biogen’s Aduhelm or so-called accelerated approval to controversial therapies like Sarepta’s Duchenne muscular dystrophy medicine Exondys 51, which is still in the midst of post-marketing studies to prove its effectiveness.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： There's an unseen cost to disruptive road

Wikipedia

focus

WSS

It's time to retire 'poor historian' from clinicians' vocabularies

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Cytokinetics CEO stresses company can launch heart drug on its own

The inclusion problem at the heart of rehabilitation research

Pumping milk in bathrooms at health conferences is common

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

leisure time

comprehensive

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Dana Farber says 6 studies to be retracted and 31 corrected

Activists slam private health insurers over coverage restrictions

Readout LOUD podcast: Live from STAT Breakthrough Summit West

What does generative AI mean for health care? We asked experts

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Hollywood unions extend contract negotiations for actors

Glen Campbell's doctor discusses his public struggle with Alzheimer's

At least 13 dead in Texas as scorching temps continue

Addiction experts warn against a second 'war on drugs'

focus

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Update the Apgar Score to remove skin color

Addiction experts warn against a second 'war on drugs'

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Update the Apgar Score to remove skin color

Wikipedia

explore

focus

Wikipedia